Status:
COMPLETED
Genetic Susceptibility to Oncogenic Viruses
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Liver Neoplasms
HIV Infections
Eligibility:
All Genders
18-100 years
Brief Summary
An NCI goal is to identify every human gene that predisposes people to cancer. Recent studies of HIV-1 indicate that genetic polymorphisms can affect susceptibility to viral infections and that such a...
Detailed Description
An NCI goal is to identify every human gene that predisposes people to cancer. Recent studies of HIV -1 indicate that genetic polymorphisms can affect susceptibility to viral infections and that such ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- 18 years or older
- Active IDU as verified by self-report and physical examination for visible signs consistent with multiple drug injection.
- EXCLUSION CRITERIA:
- Subject unable to give informed consent.
Exclusion
Key Trial Info
Start Date :
June 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 5 2007
Estimated Enrollment :
2580 Patients enrolled
Trial Details
Trial ID
NCT00341484
Start Date
June 1 1998
End Date
June 5 2007
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94115